Académique Documents
Professionnel Documents
Culture Documents
Urinalysis
Complete blood count
Blood urea nitrogen and creatinine levels
Prostate-specific antigen
Drug Therapy
Antispasmotic
Complications
Urinary incontinence
Sphincture damage
Erectile dysfunction
Pudental nerve damage
Cryoablation
Radiation therapy
Hormonal therapy
Chemotherapy
Targeted therapy
Erectile Dysfunction
Prostglandin E is a self-administered
suppository that is placed in the urethra
with an applicator.
Erection occurs in about 10 minutes and
lasts 30 to 60 minutes.
Burning of the urethra occurs after
application.
Intracorporal Injections
Injecting the penis with vasoconstricting
drugs
Phentolamine and alprostadil
Adverse effects include:
Priapism
Penile scarring
Fibrosis
Bleeding
(Continued)
Intracorporal Injections
(Continued)
Bruising
Pain
Infection
Vasovagal responses
Prosthesis
(Continued)
Potential for Metastasis
(Continued)
Postoperative care; expected problems
include:
Pain from surgical incisions
Immobility
Injuries related to invasive catheters or tubes
Nonsurgical Management
Chemotherapy
Radiation therapy
Stem cell transplantation
Hydrocele